Adenocarcinome de l'endometre sous traitement contraceptif par medroxyprogesterone. [Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone]
Details
Serval ID
serval:BIB_77D6CB14A2CF
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Adenocarcinome de l'endometre sous traitement contraceptif par medroxyprogesterone. [Adenocarcinoma of the endometrium while undergoing contraceptive treatment with medroxyprogesterone]
Journal
Revue Médicale de la Suisse Romande
ISSN
0035-3655 (Print)
Publication state
Published
Issued date
11/1981
Volume
101
Number
11
Pages
913-7
Notes
Case Reports
Journal Article --- Old month value: Nov
Journal Article --- Old month value: Nov
Keywords
Adenocarcinoma/*diagnosis/drug therapy
Adult
Female
Humans
*Medroxyprogesterone
Metrorrhagia/diagnosis
Uterine Neoplasms/*diagnosis/drug therapy
with injectable medroxyprogesterone acetate in January 1978, in July 1980
severe metrorrhagia appeared and continued until December 1980 when an
exploratory curettage revealed the existence of endometrial carcinoma.
This diagnosis was confirmed by hysterectomy. Cases such as the one
presented here are extremely rare, since medroxyprogesterone is commonly
used to cure endometrial cancer. It is possible, that the adenocarcinoma
was not hormone dependent since the patient was not yet menopausal, obese,
or diabetic, and the dose of medroxyprogesterone used was insufficient to
stop the evolution of the endometrial carcinoma. In the published
literature there are no cases similar to the one presented here. In case
of persistent metrorrhagia in patients treated with medroxyprogesterone
acetate, an exploratory curettage is absolutely necessary.
Pubmed
Create date
25/01/2008 16:39
Last modification date
20/08/2019 15:34
Usage data
